Julie Biel on Healthcare Investments and AI Market Risks

Attractive Healthcare Investments

• 🎯 Healthcare is highlighted as an attractive sector due to its resilience, particularly in small and midcap companies.
• 💡 Companies like West Pharmaceutical and Merit Medical are favored for their diversified businesses and lack of heavy reliance on single products, unlike some small-cap pharma.
• 📈 West Pharmaceutical is noted for benefiting from GLP1s and maintaining strong market share, offering earnings stability.

Niche Markets and Valuations

• 💰 Midcap and large-cap healthcare are preferred for more attractive valuations and longer growth runways.
• 🧩 Niche markets, often with less competition, help companies protect earnings resilience and maintain growth prospects.
• ⚠️ Companies supplying surgeons with specific tools face less regulatory risk related to pricing compared to larger pharmaceutical firms.

AI Dependence and Market Concerns

• ⚠️ The current market setup is challenging due to a dependence on AI working out as anticipated.
• 📉 A swing towards non-earning, unprofitable companies, especially in small caps, is a concern.
• 🏦 Investors are spooked by AI investments being funded by debt rather than cash flows, citing examples like Meta's financing and OpenAI's need for debt backstops.
• ⚡ While long-term AI fundamentals are strong, the timing and economic models for integration remain uncertain.